Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reinventing clinical trials.

Literature DB >> 22231093

Reinventing clinical trials.

Malorye Allison.

Abstract

Mesh：

Year: 2012 PMID： 22231093 DOI： 10.1038/nbt.2083

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

15 in total

1. Biomarker-led adaptive trial blazes a trail in breast cancer.

Authors: Malorye Allison
Journal: Nat Biotechnol Date: 2010-05 Impact factor: 54.908

2. 2009 FDA drug approvals.

Authors: Bethan Hughes
Journal: Nat Rev Drug Discov Date: 2010-02 Impact factor: 84.694

3. Spending on new drug development1.

Authors: Christopher Paul Adams; Van Vu Brantner
Journal: Health Econ Date: 2010-02 Impact factor: 3.046

4. Trial watch: phase III and submission failures: 2007-2010.

Authors: John Arrowsmith
Journal: Nat Rev Drug Discov Date: 2011-02 Impact factor: 84.694

5. Fresh from the biologic pipeline--2010.

Authors: Jim Kling
Journal: Nat Biotechnol Date: 2011-03 Impact factor: 54.908

6. The placebo effect in irritable bowel syndrome trials: a meta-analysis.

Authors: S M Patel; W B Stason; A Legedza; S M Ock; T J Kaptchuk; L Conboy; K Canenguez; J K Park; E Kelly; E Jacobson; C E Kerr; A J Lembo
Journal: Neurogastroenterol Motil Date: 2005-06 Impact factor: 3.598

7. Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study. IMDIAB Study Group. Immunotherapy Diabetes.

Authors: P Pozzilli; N Visalli; R Buzzetti; M G Cavallo; G Marietti; M Hawa; R D Leslie
Journal: Metabolism Date: 1998-10 Impact factor: 8.694

8. The BATTLE trial: personalizing therapy for lung cancer.

Authors: Edward S Kim; Roy S Herbst; Ignacio I Wistuba; J Jack Lee; George R Blumenschein; Anne Tsao; David J Stewart; Marshall E Hicks; Jeremy Erasmus; Sanjay Gupta; Christine M Alden; Suyu Liu; Ximing Tang; Fadlo R Khuri; Hai T Tran; Bruce E Johnson; John V Heymach; Li Mao; Frank Fossella; Merrill S Kies; Vassiliki Papadimitrakopoulou; Suzanne E Davis; Scott M Lippman; Waun K Hong
Journal: Cancer Discov Date: 2011-06-01 Impact factor: 39.397

9. Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors.

Authors: J A Wagner; E C Wright; M M Ennis; M Prince; J Kochan; D J R Nunez; B Schneider; M-D Wang; Y Chen; S Ghosh; B J Musser; M T Vassileva
Journal: Clin Pharmacol Ther Date: 2009-06-24 Impact factor: 6.875

10. Placebos without deception: a randomized controlled trial in irritable bowel syndrome.

Authors: Ted J Kaptchuk; Elizabeth Friedlander; John M Kelley; M Norma Sanchez; Efi Kokkotou; Joyce P Singer; Magda Kowalczykowski; Franklin G Miller; Irving Kirsch; Anthony J Lembo
Journal: PLoS One Date: 2010-12-22 Impact factor: 3.240

23 in total

Review 1. Human pharmacology of positive GABA-A subtype-selective receptor modulators for the treatment of anxiety.

Authors: Xia Chen; Joop van Gerven; Adam Cohen; Gabriel Jacobs
Journal: Acta Pharmacol Sin Date: 2018-12-05 Impact factor: 6.150

2. Monitoring in clinical trials: benefit or bias?

Authors: Cecilia Nardini
Journal: Theor Med Bioeth Date: 2013-08

3. A pumpless body-on-a-chip model using a primary culture of human intestinal cells and a 3D culture of liver cells.

Authors: Huanhuan Joyce Chen; Paula Miller; Michael L Shuler
Journal: Lab Chip Date: 2018-07-10 Impact factor: 6.799

4. Analysis of the lipidome of xenografts using MALDI-IMS and UHPLC-ESI-QTOF.

Authors: Roberto Fernández; Sergio Lage; Beatriz Abad-García; Gwendolyn Barceló-Coblijn; Silvia Terés; Daniel H López; Francisca Guardiola-Serrano; M Laura Martín; Pablo V Escribá; José A Fernández
Journal: J Am Soc Mass Spectrom Date: 2014-04-24 Impact factor: 3.109